Facebook Twitter YouTube Google Plus

C.) Cancer Genetics in the Mesothelioma Family

Jill Ohar, MD, FCCP
Wake Forest University

Dr. Jill Ohar graduated from Muhlenberg College in 1973 and the Medical College of Pennsylvania in 1977. She completed an internship at the Medical College of Pennsylvania, a residency in internal medicine and a fellowship in critical care and pulmonary diseases at the Medical College of Virginia. She was on faculty at Saint Louis University for 17 years. Dr. Ohar now serves as the chief of clinical operations and precepts the fellow clinics at Wake Forest School of Medicine. Dr. Ohar also spends 1/3 of the year caring for patients in the intensive care unit. Her clinical research interests focus on inhalational diseases such as COPD (chronic bronchitis and emphysema) and asbestos related diseases such as mesothelioma and asbestosis. Her current focus is based on years of research, which have determined that there is a strong tendency for mesothelioma to run in families and tends to be associated with a family history of cancer, which suggests genetic susceptibility.

Click here to view the slides for "Cancer Genetics in the Mesothelioma Family" by Jill Ohar, MD, FCCP.

To view the video presentation, please click on the image below.

© 2009 Mesothelioma Applied Research Foundation, Inc. All rights reserved. 501(c)(3)

A.) Effective Advocacy and the Case for Federal Meso Research Funding

B.) State Assistance on Insurance Appeals

C.) Cancer Genetics in the Mesothelioma Family

D.) Fundraising

E.) Navigating Mesothelioma Clinical Trials with GPS (Getting Personalized Service)

F.) Update from Across the Pond

G.) The Mesothelioma Experience: Patient and Provider Perspectives Panel

H.) Work of the Science Advisory Board

J.) Present and Future of Mesothelioma Treatment: Medical Oncologist and Researcher Perspective

K.) New Developments in Radiation Oncology: A Global Perspective

M.) Pain Management

Mesothelioma Treatment: Present & Future from a Surgeon & Research Perspective | Dr. Harvey Pass

N.) Traditional Healing with Modern Science

O.) Update on Clinical Trials and Mesothelioma Research

P.) Mesothelioma Tissue Bank

Photodynamic Therapy for Mesothelioma Treatment | Dr. Joseph Friedberg

Q.) EGFR Inhibitors for Patients with Malignant Peritoneal Mesothelioma

R.) The Use of Cytokine Inhibitors: Translational Lab Results

S.) Identifying and Targeting Aggressive Malignant Peritoneal Mesothelioma: Morphologic and Molecular Studies

T.) Treatment Options for Patients with Recurrent Disease after HIPEC, HRA - Panel Discussion